Mr. Shafin Diamond Tejani reports
VICTORY SQUARE TECHNOLOGIES PORTFOLIO COMPANY'S LEISHMANIASIS RAPID TEST RECEIVES BRAZILIAN MAPA APPROVAL FOR SALE & USE FOR THE COUNTRY OF BRAZIL AND ENTERS INTO A SALES & DISTRIBUTION CONTRACT WITH ECODIAGNOSTICA OF BRAZIL
Victory Square Health Inc./Safetest -- a portfolio company of Victory Square Technologies Inc. -- has been granted approval by the Brazilian Ministry of Agriculture, Livestock and Food Supply (MAPA) to commence marketing, sales and distribution for its Leishmaniasis rapid test in Brazil and export to Mercosur countries (Argentina, Paraguay, Uruguay and Venezuela) in Central and South America. The company entered into a sales and distribution contract and formal partnership for the Leishmaniasis test with Ecodiagnostica of Brazil.
Leishmaniasis is one of the world's most neglected diseases and VS Health is strategically positioned to address this unmet need for quick and reliable testing.
Leishmaniasis is a parasitic disease that affects humans and canines in Southern Europe, Central America, South America, Mexico and the Middle East. About four million to 12 million people are currently infected
in about 98 countries.
About two million new cases
occur annually that if undetected and untreated can cause disabilities and death. About 200 million people in Asia, Africa, South and Central America, and southern Europe live in areas where the disease is common.
VS Health has developed and validated the clinical performance of its Leishmaniasis diagnostic test with a results that exceeds currently available tests with greater sensitivity and specificity in correctly diagnosing Leishmaniasis both in humans and canines with a sensitivity of 93.2 per cent and specificity of a leading 91.3 per cent.
The company is pleased to have entered into a partnership, sales and distribution contract with Ecodiagnostica of Brazil for the sale of the Leishmaniasis test for South America. Ecodiagnostica manufactures and distributes products for the market of human diagnosis, veterinary and food safety. Founded in 2012, Ecodiagnostica is based in Nova Lima, Brazil, and has extensive sales and distribution networks across South America and beyond. Ecodiagnostica has placed an initial order of the VSH Leishmaniasis test at time of release.
"I am very pleased to announce our latest approval for another one of our tests in partnership with Ecodiagnostica. Our Leishmaniasis test is just one of many tests currently approved or in our development pipeline. Our global distribution and sales network has grown exponentially with our numerous approvals of our Safetest COVID-19 testing products. These new avenues and new partnership agreements will provide this test and others with easy access to key markets," said Felipe Peixoto, chief executive officer of Victory Square Health.
VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient's care and improve health outcomes. Its first product, the Leishmaniasis rapid test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D (research and development) pipelines of diagnostic kits for Hansen's disease, brucellosis, HTLV and blood samples screening tests.
The company is not making any express or implied claims that its product has the ability to eliminate, cure or contain COVID-19 (or SARS-2 coronavirus) at this time.
About Victory Square Technologies Inc.
Victory Square builds, acquires and invests in promising start-ups, then provides the senior leadership and resources needed to fast-track growth.
The company's sweet spot is the cutting-edge tech that is shaping the fourth industrial revolution. The company's portfolio consists of 20 global companies using artificial intelligence, virtual reality/augmented reality and blockchain to disrupt sectors as diverse as financial technology, insurance, health and gaming.
What the company does differently for start-ups
Victory Square is not just another investor. With real skin in the game, it is committed to ensuring each company in its portfolio succeeds. The company's secret sauce starts with selecting start-ups that have real solutions, not just ideas. It pairs you with senior talent in product, engineering, customer acquisition and more. Then it lets you do what you do best -- build, innovate and disrupt. In 24 to 36 months, you will scale and be ready to monetize.
What the company does differently for investors
Victory Square is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).
For investors, the company offers early-stage access to the next unicorns before they are unicorns.
Its portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.